Managing Controlled Substances in Everyday Prescribing
The landscape of prescribing practices is constantly evolving, and clinicians must stay informed to ensure responsible prescribing of controlled substances.
Opioids
FDA Launches “Remove the Risk” Campaign for Safe Disposal of Unused Opioids
The U.S. Food and Drug Administration is launching on April 25, 2019, its “Remove the Risk” campaign, aimed at promoting the safe disposal of unused opioids.
CDC Provides Clarification of Opioid Prescribing Guideline
Misapplication of the guideline can put patient health and safety at risk.
FDA Approves First Generic Nasal Spray Against Opioid Overdose
The first generic naloxone nasal spray to treat opioid overdose has received approval from the US Food and Drug Administration.
Persistent Postsurgical Opioid Use in Youth Associated With Long-Term Use of Opioids by Relatives
Persistent opioid use in opioid-naive adolescents and young adults undergoing surgery or dental procedures may be associated with long-term use of opioids by a relative.
In Pregnancy, Buprenorphine Use Up, Methadone Use Down
And the 4Ps Plus and SURP-P scale are sensitive for identifying illicit drug use in pregnancy
Evidence-Based Medicine in Acute Pediatric Migraine Associated With Demographics
The demographic characteristics and migraine diagnosis of pediatric patients with headache were found to be associated with the use of evidence-based medicine and prescriptions for opioids and barbiturates as first-line treatment.
Opioid Prescription of 4 to 7 Days May Be Sufficient for Acute Pain Management
An initial prescription of opioids for 4 to 7 days for the management of acute pain in the primary care setting was found to be sufficient.
The Role of Physicians in Addressing the Opioid Crisis
A 5-point strategy has been proposed for combatting the opioid crisis.
Opioid Prescriptions Dropped for New Users From 2012 to 2017
Many providers stopped initiating opioid therapy from July 2012 to December 2017.
Next post in Pain Information Center
